Why is Atarax (hydroxyzine) absolutely contraindicated in patients aged 65 years and older?

Atarax (Hydroxyzine) is NOT Absolutely Contraindicated in Patients Over 65

There is no absolute contraindication for prescribing Atarax (hydroxyzine) to patients over age 65, but it requires extreme caution and is considered potentially inappropriate medication in this population due to significant anticholinergic burden and associated risks.

Why the Confusion Exists

The FDA drug label for Atarax does not list age over 65 as an absolute contraindication 1. However, hydroxyzine is prominently featured on the American Geriatrics Society Beers Criteria as a potentially inappropriate medication for older adults 2, which is often misinterpreted as an absolute contraindication.

The Real Concerns in Elderly Patients

Anticholinergic Burden and Cognitive Decline

First-generation antihistamines like hydroxyzine have strong anticholinergic effects that are particularly dangerous in elderly patients 3, 4. The anticholinergic cognitive burden is associated with:

• Cognitive decline and confusion - Multiple studies document that anticholinergic medications adversely affect cognition and functional status in older adults 3
• Delirium risk - Sedating drugs with anticholinergic properties cause confusion and over-sedation in the elderly 1
• Functional decline - The Drug Burden Index shows these medications are associated with decline in activities of daily living (ADL) scores 3

Increased Adverse Event Risk

Elderly patients face heightened risks from hydroxyzine:

• Falls and injuries - The combination of sedation and anticholinergic effects increases fall risk 3
• Emergency department visits and hospitalizations - These complications raise the cost of care significantly 3
• Cardiovascular events - Patients with MCAS who are prone to cardiovascular events face particular concern with first-generation antihistamines 4
• Urinary retention and constipation - Broad muscarinic receptor blockade affects urination and bowel function 3

Altered Pharmacokinetics

Hydroxyzine has dramatically prolonged effects in elderly patients 5:

• Elimination half-life of 29.3 hours in elderly subjects (compared to shorter in younger adults)
• Volume of distribution of 22.5 L/kg - extremely large
• Prolonged suppressive effects lasting up to 144 hours after a single dose
• Reduced renal function (even without overt disease) increases susceptibility to drug accumulation 1

Clinical Guidance for Use in Elderly

When Hydroxyzine Might Be Considered

If hydroxyzine must be used in patients ≥65 years:

1. Start with the lowest possible dose - The FDA label recommends starting at the low end of the dosing range 1
2. Reduce the dose by half in patients with renal impairment 6
3. Avoid in severe liver disease - The sedating effect is inappropriate and dangerous 6
4. Monitor closely for sedation, confusion, falls, and cognitive changes 1
5. Limit duration - Use for the shortest time possible given the prolonged effects 5

Safer Alternatives

Second-generation antihistamines (cetirizine, fexofenadine, loratadine) should be strongly preferred 7, 4:

• Minimal anticholinergic effects
• Less sedation
• Better cognitive safety profile
• Oral formulations have the best safety profile 7

Absolute Avoidance Situations

Hydroxyzine should be absolutely avoided in elderly patients with:

• Severe hepatic impairment - Risk of precipitating coma 6
• Severe renal impairment (creatinine clearance <10 mL/min) 6
• Cognitive impairment or dementia - Anticholinergic burden will worsen cognition 3
• History of falls - Sedation and anticholinergic effects increase fall risk
• Concurrent use of other CNS depressants - Potentiating effects require dose reduction 1

Common Pitfalls to Avoid

1. Don't assume hydroxyzine is equivalent to diphenhydramine - While both are problematic, hydroxyzine actually has fewer antimuscarinic findings than diphenhydramine in overdose 8

2. Don't prescribe "as needed" without clear limits - Given the 29-hour half-life in elderly patients, accumulation occurs rapidly with repeated dosing 5

3. Don't ignore the prescribing cascade - New symptoms (confusion, urinary retention, constipation) may be adverse effects, not new conditions requiring additional medications 9

4. Don't combine with other anticholinergic medications - The cumulative anticholinergic burden dramatically increases risk 3

Bottom Line

Hydroxyzine is not absolutely contraindicated in patients over 65, but it is potentially inappropriate and should be avoided whenever safer alternatives exist 2. When no alternative is available, use the lowest effective dose for the shortest duration with close monitoring for cognitive, functional, and safety outcomes 3, 1.